Special Issue "New Approaches for the Treatment of Civilization Diseases"
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 8815
Civilization diseases are called the epidemy of the 21st century. They spread globally, are non-contagious, yet lead to disability and result in over 80% of premature deaths. Living in a hurry, full of stressful stimuli, poor nutrition, as well as climate change and using stimulants are the causes that often lead to a shortening of life expectancy or significantly reduce its quality. The most often diseases of civilization include disorders of the cardiovascular system, obesity, atherosclerosis, diabetes, cancer, allergies and osteoporosis as well as disorders of the central systemsuch as mental (eg. schizophrenia) and neurodegenerative diseases (Parkinson’s and Alzheimer’s disease). The number of patients with depression, neurosis and schizophrenia is increasing. Despite the continuous progress of medical science and the introduction of new drugs to the market, the effectiveness of treatment of many diseases remains unsatisfactory. One of the major problems with pharmacotherapy is the large variability in patients' response to the drug. Therefore, it is necessary to individualize the treatment and to optimize the substances of the pharmacotherapy used. In this special issue, we invite potential authors to submit manuscripts regarding the discovery of anti-cancer, anti-diabetes, anti-tuberculosis and drugs for mental and neurodegenerative diseases. Publications covering, inter alia, the synthesis, mechanism of action and biological activity of the compounds are welcome. Both original and review article contributions will be welcome.
Dr. Monika Pitucha
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.